Literature DB >> 17985377

Classification of coronary artery bifurcation lesions and treatments: time for a consensus!

Yves Louvard1, Martyn Thomas, Vladimir Dzavik, David Hildick-Smith, Alfredo R Galassi, Manuel Pan, Francisco Burzotta, Michael Zelizko, Darius Dudek, Peter Ludman, Imad Sheiban, Jens F Lassen, Olivier Darremont, Adnan Kastrati, Josef Ludwig, Ioannis Iakovou, Philippe Brunel, Alexandra Lansky, David Meerkin, Victor Legrand, Alfonso Medina, Thierry Lefèvre.   

Abstract

BACKGROUND: Percutaneous coronary intervention (PCI) of coronary bifurcation lesions remains a subject of debate. Many studies have been published in this setting. They are often small scale and display methodological flaws and other shortcomings such as inaccurate designation of lesions, heterogeneity, and inadequate description of techniques implemented.
METHODS: The aim is to propose a consensus established by the European Bifurcation Club (EBC), on the definition and classification of bifurcation lesions and treatments implemented with the purpose of allowing comparisons between techniques in various anatomical and clinical settings.
RESULTS: A bifurcation lesion is a coronary artery narrowing occurring adjacent to, and/or involving, the origin of a significant side branch. The simple lesion classification proposed by Medina has been adopted. To analyze the outcomes of different techniques by intention to treat, it is necessary to clearly define which vessel is the distal main branch and which is (are) the side branche(s) and give each branch a distinct name. Each segment of the bifurcation has been named following the same pattern as the Medina classification. The classification of the techniques (MADS: Main, Across, Distal, Side) is based on the manner in which the first stent has been implanted. A visual presentation of PCI techniques and devices used should allow the development of a software describing quickly and accurately the procedure performed.
CONCLUSION: The EBC proposes a new classification of bifurcation lesions and their treatments to permit accurate comparisons of well described techniques in homogeneous lesion groups. Copyright 2008 Wiley-Liss, Inc.

Entities:  

Mesh:

Year:  2008        PMID: 17985377     DOI: 10.1002/ccd.21314

Source DB:  PubMed          Journal:  Catheter Cardiovasc Interv        ISSN: 1522-1946            Impact factor:   2.692


  46 in total

1.  Clinical outcome after percutaneous treatment of de novo coronary bifurcation lesions using first or second generation of drug-eluting stents.

Authors:  Miroslaw Ferenc; Heinz Joachim Buettner; Michael Gick; Thomas Comberg; Juergen Rothe; Firas Khoury; Christian Valina; Aurel Toma; Piotr Kuebler; Florian Riede; Franz-Josef Neumann
Journal:  Clin Res Cardiol       Date:  2015-09-02       Impact factor: 5.460

Review 2.  Update on Provisional Technique for Bifurcation Interventions.

Authors:  Lazzaro Paraggio; Francesco Burzotta; Cristina Aurigemma; Carlo Trani
Journal:  Curr Cardiol Rep       Date:  2016-03       Impact factor: 2.931

3.  The paclitaxel-eluting PTCA-balloon in combination with a cobalt-chromium stent in two different sequences to treat de novo coronary artery lesions: an angiographic follow up study.

Authors:  Upendra Kaul; Martin Unverdorben; Ralf Degenhardt; Ashok Seth; Vinay K Bahl; Shirish M S Hiremath; Praveen Chandra; Ajit S Mullesari; P S Sandhu; Seshagiri Rao; Oommen George; Hanns Ackermann; Michael Boxberger
Journal:  Indian Heart J       Date:  2013-09-13

4.  New strategies in the treatment of coronary bifurcations.

Authors:  I Iakovou; N Foin; A Andreou; N Viceconte; C Di Mario
Journal:  Herz       Date:  2011-05       Impact factor: 1.443

5.  2014 ACC/AHA Key Data Elements and Definitions for Cardiovascular Endpoint Events in Clinical Trials: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Data Standards (Writing Committee to Develop Cardiovascular Endpoints Data Standards).

Authors:  Karen A Hicks; James E Tcheng; Biykem Bozkurt; Bernard R Chaitman; Donald E Cutlip; Andrew Farb; Gregg C Fonarow; Jeffrey P Jacobs; Michael R Jaff; Judith H Lichtman; Marian C Limacher; Kenneth W Mahaffey; Roxana Mehran; Steven E Nissen; Eric E Smith; Shari L Targum
Journal:  J Nucl Cardiol       Date:  2015-10       Impact factor: 5.952

6.  Angiographic study of the clinical liaison of drug-eluting stent and paclitaxel-eluting balloon in unifocal side branch ostium stenosis (ASCLEPIUS).

Authors:  Man-Hong Jim; Eugene Brian Wu; Chi-Yuen Chan; Ka-Lam Wong; Raymond Chi-Yan Fung; Kai-Hang Yiu
Journal:  Heart Vessels       Date:  2017-03-29       Impact factor: 2.037

Review 7.  Treatment of Bifurcation Lesions: Has DK Crush"ed" the Competition?

Authors:  Bryce S Lynn; James B Hermiller
Journal:  Curr Cardiol Rep       Date:  2018-09-01       Impact factor: 2.931

8.  Effect of stenosis eccentricity on the functionality of coronary bifurcation lesions-a numerical study.

Authors:  Catherine Pagiatakis; Jean-Claude Tardif; Philippe L L'Allier; Rosaire Mongrain
Journal:  Med Biol Eng Comput       Date:  2017-05-13       Impact factor: 2.602

Review 9.  Recent perspective on coronary artery bifurcation interventions.

Authors:  Debabrata Dash
Journal:  Heart Asia       Date:  2014-02-14

10.  One-stent versus two-stent techniques for distal unprotected left main coronary artery bifurcation lesions.

Authors:  Jiangang Zhang; Shuai Liu; Tao Geng; Zesheng Xu
Journal:  Int J Clin Exp Med       Date:  2015-08-15
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.